Normal function · from ai-gene-review (P49768, commit 79fe13b38970) · AI-generated, not KB evidence

Presenilin-1 is a multi-pass membrane aspartyl protease subunit of the gamma-secretase complex. After endoproteolytic maturation, presenilin-1 N- and C-terminal fragments assemble with nicastrin, APH1, and PEN2 in secretory and endosomal membranes to cleave type I membrane-protein substrates, including APP and Notch receptors. Through this intramembrane protease activity, PSEN1 contributes to amyloid-beta peptide generation, Notch receptor processing, and broader regulated intramembrane proteolysis. Additional evidence links presenilin holoprotein to endoplasmic-reticulum calcium leak/homeostasis and protein-trafficking interactions, but these are secondary to its core gamma-secretase catalytic role.

PSEN1 is the catalytic presenilin subunit of the mature gamma-secretase complex, a multi-pass membrane aspartyl protease that cleaves type I membrane-protein substrates after ectodomain shedding.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
Dilated Cardiomyopathy 1U disputed germline
mechanism: PSEN1 Asp333Gly Missense Variant in Cardiomyocytes
animal model: Cardiovascular-restricted Psen1 conditional knockout mouse
Early-Onset Autosomal Dominant Alzheimer Disease causative germline
mechanism: Pathogenic APP, PSEN1, or PSEN2 Germline Variant
subtype: PSEN1
scoped to subtype: PSEN1
Hidradenitis Suppurativa causative
mechanism: Gamma-Secretase Loss of Function
subtype: AI3
scoped to subtype: AI3
Alzheimer Disease untyped
Genetic Mutation
mechanism: Amyloid Plaque Formation; Neuronal Endosomal-Lysosomal Acidification Failure
scoped to subtype: Early-Onset Alzheimer's Disease
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
dilated cardiomyopathy 1U MONDO:0013371 AD Disputed
2026-03-04
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.